Investigating the chlorination of acidic pharmaceuticals and by-product formation aided by an experimental design methodology

Water Research

Volumn 44, Issue 1, 2010, Pages 243-255

  Quintana, José Benito ^a,b   Rodil, Rosario ^a,b   López Mahía, Purificación ^b   Muniategui Lorenzo, Soledad ^b   Prada Rodríguez, Darío ^b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Acidic pharmaceuticals; By products; Chlorination; Environmental fate; Liquid chromatography mass spectrometry (LC MS); Non steroidal anti inflammatory drugs (NSAIDs); Time of flight (TOF)

Indexed keywords

BYPRODUCTS; CARBOXYLATION; CHLORINATION; DEGRADATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; POTABLE WATER; PRODUCT DESIGN; STATISTICS;

ACIDIC PHARMACEUTICALS; ENVIRONMENTAL FATE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; TIME OF FLIGHT;

SALICYLIC ACID;

BEZAFIBRATE; BROMIDE; CHLORINE; CLOFIBRIC ACID; DICLOFENAC; DRINKING WATER; FENOPROFEN; HYDROGEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; SALICYLIC ACID;

CHLORINATION; DEGRADATION; DRINKING WATER; DRUG; ENVIRONMENTAL FATE; EXPERIMENTAL DESIGN; METABOLITE; SALICYLIC ACID; WASTEWATER;

ACIDITY; ARTICLE; CHLORINATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DECARBOXYLATION; DEGRADATION KINETICS; DRUG DEGRADATION; DRUG HALF LIFE; DRUG STRUCTURE; HALOGENATION; HYDROXYLATION; LIQUID CHROMATOGRAPHY; METHODOLOGY; OXIDATION; PH; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT;

EID: 71849104062     PISSN: 00431354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.watres.2009.09.018     Document Type: Article

References (36)

1. Bedner M., and Maccrehan W.A. Transformation of acetaminophen by chlorination produces the toxicants 1,4-benzoquinone and N-acetyl-p-benzoquinone imine. Environ. Sci. Technol. 40 2 (2006) 516-522
2. Boyd G.R., Reemtsma H., Grimm D.A., and Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 311 1-3 (2003) 135-149
3. Canosa P., Rodríguez I., Rubí E., Negreira N., and Cela R. Formation of halogenated by-products of parabens in chlorinated water. Anal. Chim. Acta 575 1 (2006) 106-113
4. Carballa, M., Omil, F., Lema, J.M., Llompart, M., Garcia-Jares, C., Rodriguez, I., Gomez, M., Ternes, T., 2004. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 38 (12), 2918-2926.
5. Drewes J.E., Heberer T., and Reddersen K. Fate of pharmaceuticals during indirect potable reuse. Water Sci. Technol. 46 3 (2002) 73-80
6. Euro Chlor, European Federation of Chlor-alkali Producers. (accessed July 2009).
7. EU. Commission Decision (2002/657/EC): implementing Council directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Communities L067 (2002) 8-36
8. Ferreira S.L.C., Bruns R.E., Ferreira H.S., Matos G.D., David J.M., Brandão G.C., da Silva E.G.P., Portugal L.A., dos Reis P.S., Souza A.S., and dos Santos W.N.L. Box-Behnken design: an alternative for the optimization of analytical methods. Anal. Chim. Acta 597 2 (2007) 179-186
9. Inaba K., Doi T., Isobe N., and Yamamoto T. Formation of bromo-substituted triclosan during chlorination by chlorine in the presence of trace levels of bromide. Water Res. 40 15 (2006) 2931-2937
10. Kim S.D., Cho J., Kim I.S., Vanderford B.J., and Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 41 5 (2007) 1013-1021
11. Kosjek T., Heath E., Petrovic M., and Barcelo D. Mass spectrometry for identifying pharmaceutical biotransformation products in the environment. Trends Anal. Chem. 26 11 (2007) 1076-1085
12. Kosjek T., and Heath E. Applications of mass spectrometry to identifying pharmaceutical transformation products in water treatment. Trends Anal. Chem. 27 10 (2008) 807-820
13. Lewis G.A., Mathieu D., and Phan-Tan-Luu R. Pharmaceutical Experimental Design in Drugs (1999), Marcel Dekker, New York
14. Metcalfe C.D., Koenig B.G., Bennie D.T., Servos M., Ternes T.A., and Hirsch R. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ. Toxicol. Chem. 22 12 (2003) 2872-2880
15. Miyamoto G., Zahid N., and Uetrecht J.P. Oxidation of diclofenac to reactive intermediates by neutrophils, myeloperoxidase, and hypochlorous acid. Chem. Res. Toxicol. 10 4 (1997) 414-419
16. Mompelat S., Le Bot B., and Thomas O. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water. Environ. Int. 35 5 (2009) 803-814
17. Negreira N., Canosa P., Rodríguez I., Ramil M., Rubí E., and Cela R. Study of some UV filters stability in chlorinated water and identification of halogenated by-products by gas chromatography-mass spectrometry. J. Chromatogr. A 1178 (2008) 206-214
18. Okuda T., Kobayashi Y., Nagao R., Yamashita N., Tanaka H., Tanaka S., Fujii S., Konishi C., and Houwa I. Removal efficiency of 66 pharmaceuticals during wastewater treatment process in Japan. Water Sci. Technol. 57 1 (2008) 65-71
19. Páxeus N. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfibrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci. Technol. 50 5 (2004) 253-260
20. Petrovic M., and Barcelo D. Analysis, Fate and Removal of Pharmaceuticals in the Water Cycle (2007), Elsevier, Amsterdam
21. Pinkston K.E., and Sedlak D.L. Transformation of aromatic ether- and amine-containing pharmaceuticals during chlorine disinfection. Environ. Sci. Technol. 38 14 (2004) 4019-4025
22. Prütz W.A. Reactions of hypochlorous acid with biological substrates are activated catalytically by tertiary amines. Arch. Biochem. Biophys. 357 2 (1998) 265-273
23. Quintana J.B., and Reemtsma T. Sensitive determination of acidic drugs and triclosan in surface and wastewater by ion-pair reverse-phase liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 18 7 (2004) 765-774
24. Quintana J.B., Weiss S., and Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 39 12 (2005) 2654-2664
25. In: Reemtsma T., and Jekel M. (Eds). Organic Pollutants in the Water Cycle (2006), Wiley VCH, Weinheim
26. Reemtsma T., Weiss S., Mueller J., Petrovic M., González S., Barcelo D., Ventura F., and Knepper T.P. Polar pollutants entry into the water cycle by municipal wastewater: a European perspective. Environ. Sci. Technol. 40 17 (2006) 5451-5458
27. Rodil R., Quintana J.B., Lopez-Mahia P., Muniategui-Lorenzo S., and Prada-Rodriguez D. Multiresidue analytical method for the determination of emerging pollutants in water by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1216 14 (2009) 2958-2969
28. Rodrigues P.M.S.M., Esteves da Silva J.C.G., and Antunes M.C.G. Factorial analysis of the trihalomethanes formation in water disinfection using chlorine. Anal. Chim. Acta 595 1-2 (2007) 266-274
29. Stackelberg P.E., Furlong E.T., Meyer M.T., Zaugg S.D., Henderson A.K., and Reissman D.B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant. Sci. Total Environ. 329 1-3 (2004) 99-113
30. Stackelberg P.E., Gibs J., Furlong E.T., Meyer M.T., Zaugg S.D., and Lippincott R.L. Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci. Total Environ. 377 2-3 (2007) 255-272
31. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., and Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res. 39 9 (2005) 1761-1772
32. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 32 11 (1998) 3245-3260
33. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.J., Gulde B.H., Preuss G., Wilme U., and Seibert N.Z. Removal of pharmaceuticals during drinking water treatment. Environ. Sci. Technol. 36 17 (2002) 3855-3863
34. Vanderford B.J., Pearson R.A., Rexing D.J., and Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal. Chem. 75 22 (2003) 6265-6274
35. Vanderford B.J., Mawhinney D.B., Rosario-Ortiz F.L., and Snyder S.A. Real-time detection and identification of aqueous chlorine transformation products using QTOF MS. Anal. Chem. 80 11 (2008) 4193-4199
36. Westerhoff P., Yoon Y., Snyder S., and Wert E. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes. Environ. Sci. Technol. 39 17 (2005) 6649-6663